Emily M. Leproust - 04 May 2023 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Chief Executive Officer, Director
Signature
/s/ Alyssa Zhang, as Attorney-in-Fact for Emily M. Leproust
Issuer symbol
TWST
Transactions as of
04 May 2023
Net transactions value
+$144,942
Form type
4
Filing time
08 May 2023, 16:00:14 UTC
Previous filing
04 May 2023
Next filing
23 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Options Exercise $144,942 +24,360 +11% $5.95 256,094 04 May 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 +24,360 $0.000000* 0 04 May 2023 Common Stock 24,360 $5.95 Direct F4
holding TWST Employee Stock Option (right to buy) 150,879 04 May 2023 Common Stock 0 $8.82 Direct F1
holding TWST Employee Stock Option (right to buy) 266,539 04 May 2023 Common Stock 0 $26.66 Direct F2
holding TWST Employee Stock Option (right to buy) 131,290 04 May 2023 Common Stock 0 $23.33 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F2 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F3 25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F4 The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.